APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,245 | -37.7% | 1,426 | +49.2% | 0.00% | -33.3% |
| Q2 2023 | $87,092 | +40.2% | 956 | +1.5% | 0.00% | +50.0% |
| Q1 2023 | $62,134 | +1523.6% | 942 | +1173.0% | 0.00% | – |
| Q4 2022 | $3,827 | -36.2% | 74 | -8.6% | 0.00% | – |
| Q3 2022 | $6,000 | +100.0% | 81 | +9.5% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 74 | -43.1% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 130 | -1.5% | 0.00% | – |
| Q4 2021 | $6,000 | +200.0% | 132 | +123.7% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 59 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 59 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 59 | -46.4% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 110 | -29.0% | 0.00% | – |
| Q2 2020 | $5,000 | – | 155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |